Our team brought Okapi Sciences from a series A in 2008 to a healthy acquisition in 2014. The same team has merged Okapi Sciences’ livestock assets with innovations at Academia to form ViroVet. Currently we are approaching 20 FTE. Our company was elected as 2015 and 2017 startup of the year by Animal Pharm News. You can meet and connect with our board members, the founders and our investors by clicking below.
Board of Directors
Founders
Investors
George Gunn
Chairman
Erwin Blomsma
CEO
Patrik Haesen
for AIF
Laetitia Gerbe
for Seventure Partners
Filip Goossens
for PMV
Ludwig Goris
for CSCF
Ilse Sienaert
for GFF / KU Leuven
Yannick Vancoppenolle
for VIVES
CEO and representative of ViroVet in the board of Flanders.Bio
Erwin Blomsma
CDO and representative of ViroVet in the board of Flanders Vaccine
Nesya Goris
COO
Stefaan Wera
AIF
Agri Investment Fund
PMV
Biotech Fonds Vlaanderen
CSCF
Capricorn Sustainable Chemistry Fund
GFF
Gemma Frisius Fund
VIVES
Louvain Technology Fund
Seventure Partners
Seventure Partners AVF Fund
